New
Celula China
The AI engine Fit Assessment
BetaCellula focuses on women's health through its engagement in reproductive health and offers advanced genetic testing solutions.
Blurb
Celula specializes in research, development, and production of clinical equipment.
HQ Location
China
Founded
2013
Employees
51 - 200
Total funding raised
$7.76M
Last Funding Event
Series B, $7.32M, September 1, 2020
Smart insights
- Catherine Msc (Chief People Officer) worked at Lilium as Head of People Business Partnering for 1.5 years (2021 - 2022)
- Val Miftakhov (Founder & CEO) worked at Google in various roles, including Head of R&D, Google for Work Incubation, for a total of 4 years (2012 - 2016)
- 6m headcount growth: 25%
- 1Y headcount growth: 94%
- Headcount-to-last-round ratio: 5.3 employees/$M
Subspaces
- Genomic and Genetic Testing
Researcher and developer of advanced genetic testing technology in the field of reproductive health. The company's technology focuses on the clinical application of cutting edge technologies in areas such as flow cytometry, and supporting reagents, non-invasive prenatal testing (NIPT), and tumor companion diagnosis through liquid biopsies, providing testing methods for various diseases.